Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKesson
AstraZeneca
Cerilliant
Deloitte
Merck
Julphar
Chinese Patent Office
Medtronic
Daiichi Sankyo

Generated: August 16, 2017

DrugPatentWatch Database Preview

DOCETAXEL Drug Profile

« Back to Dashboard

What is the patent landscape for Docetaxel, and what generic Docetaxel alternatives are available?

Docetaxel is a drug marketed by Apotex Inc, Sandoz, Hospira Inc, Eagle Pharms, Actavis Llc, Pfizer Labs, Jiangsu Hengrui Med, Dfb Oncology Ltd, Teva Pharms Usa, Dr Reddys Labs Ltd, and Accord Hlthcare. and is included in eleven NDAs. There are two patents protecting this drug.

This drug has fifteen patent family members in fifteen countries.

The generic ingredient in DOCETAXEL is docetaxel. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the docetaxel profile page.

Summary for Tradename: DOCETAXEL

Patents:2
Applicants:11
NDAs:11
Suppliers / Packagers: see list12
Bulk Api Vendors: see list59
Clinical Trials: see list1,810
Patent Applications: see list9,845
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOCETAXEL at DailyMed

Pharmacology for Tradename: DOCETAXEL

Drug ClassMicrotubule Inhibitor
Physiological EffectMicrotubule Inhibition
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
DOCETAXEL
docetaxel
INJECTABLE;INJECTION204193-001Nov 5, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Dfb Oncology Ltd
DOCETAXEL
docetaxel
INJECTABLE;INJECTION206177-002Jan 20, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
DOCETAXEL
docetaxel
INJECTABLE;INJECTION204193-002Nov 5, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Dfb Oncology Ltd
DOCETAXEL
docetaxel
INJECTABLE;INJECTION206177-003Jan 20, 2017RXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION022312-001Jan 11, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: DOCETAXEL

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014055426► Subscribe
Mexico2015003824► Subscribe
Australia2013327563► Subscribe
Singapore11201502352W► Subscribe
Canada2885930► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: DOCETAXEL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
172Luxembourg► SubscribePRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
/2013Austria► SubscribePRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317
60002Netherlands► SubscribePRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Novartis
Medtronic
Fuji
Farmers Insurance
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot